Insights by
Viktor
August 2023 Roundup of HTA Decisions in Three Top European Markets and a Perspective on How to Sustain a High ASMR Score at Reassessment by HAS
July 2023 Roundup of HTA Decisions in Oncology and a Perspective on the UK Cancer Drugs Fund (CDF)
Need help?
Contact us today.
We're excited to learn about your strategic business objectives and brainstorm how to help you achieve them.
Want to Join
Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.